Colorectal and anal neoplasms following liver transplantation

Colorectal Disease

Volumn 12, Issue 7, 2010, Pages 657-666

  Albright, J B ^a,b   Bonatti, H ^b,c   Stauffer, J ^b   Dickson, R C ^b   Nguyen, J ^b   Harnois, D ^b   Jeanpierre, C ^b   Hinder, R ^b   Steers, J ^d   Chua, H ^e   Aranda Michel, J ^b  

^a Department of Surgery   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d ST LUKE S MEDICAL CENTER   (United States)

^e MAYO CLINIC ROCHESTER   (United States)

Author keywords

Adenocarcinoma; Anal neoplasms; Colonic neoplasms; Human papilloma virus; Liver transplantation; Polyps; PTLD; Rectal neoplasms

Indexed keywords

CYCLOSPORIN A; GANCICLOVIR; IMMUNOGLOBULIN G ANTIBODY; MYCOPHENOLIC ACID; OKT 3; ORTHOCLONE; RAPAMYCIN; STEROID; TACROLIMUS; UNCLASSIFIED DRUG; VALACICLOVIR;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ALCOHOL LIVER DISEASE; ANAL INTRAEPITHELIAL NEOPLASIA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; COLON ADENOCARCINOMA; COLON ADENOMA; COLON BIOPSY; COLON POLYP; COLON RESECTION; COLONOSCOPY; COLORECTAL TUMOR; CROHN DISEASE; CYTOMEGALOVIRUS INFECTION; DIARRHEA; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOCHEZIA; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECTUM TUMOR; SEROLOGY; ULCERATIVE COLITIS; WART VIRUS;

ADOLESCENT; ADULT; AGED; ANUS NEOPLASMS; COLONIC NEOPLASMS; COLONOSCOPY; FEMALE; FLORIDA; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 77958121852     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2009.01840.x     Document Type: Article

References (55)

1. Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 1993; 7: 431-45.
2. Aigner F, Boeckle E, Albright J et al. Malignancies of the colorectum and anus in solid organ recipients. Transpl Int 2007; 20: 497-504.
3. Buell JF, Papaconstantinou HT, Skalow B, Hanaway MJ, Alloway RR, Woodle ES. De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population. Transplant Proc 2005; 37: 960-1.
4. Parikshak M, Pawlak SE, Eggenberger JC, Lee CS, Szilagy EJ, Margolin DA. The role of endoscopic colon surveillance in the transplant population. Dis Colon Rectum 2002; 45: 1655-60.
5. Atassi T, Thuluvath PJ. Risk of colorectal adenoma in liver transplant recipients compared to immunocompetent control population undergoing routine screening colonoscopy. J Clin Gastroenterol 2003; 37: 72-3.
6. Bonatti HSR, Dickson RC, Razonable R, Schmitt T, Mendez J, Singh N. Pruett transmission of viral disease to the recipient through the donor liver. Curr Opin Organ Transplant 2007; 12: 231-41.
7. Rudraraju M, Osowo AT, Singh V, Carey EJ. Do patients need more frequent colonoscopic surveillance after liver transplantation? Transplant Proc 2008; 40: 1522-4.
8. Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O'Brien MJ, Levin B et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin 2006; 56: 143-59.
9. Winawer SJ, Zauber AG, O'Brien MJ, Ho MN, Gottlieb L, Sternberg SS et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 1993; 328: 901-6.
10. Frisch M, Glimelius B, van den Brule AJ, Wohlfahrt J, Meijer CJ, Walboomers JM et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337: 1350-8.
11. Harwood CA, Surentheran T, McGregor JM, Spink PJ, Leigh IM, Breuer J et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000; 61: 289-97.
12. Johnson EE, Leverson GE, Pirsch JD, Heise CP. A 30-year analysis of colorectal adenocarcinoma in transplant recipients and proposal for altered screening. J Gastrointest Surg 2007; 11: 272-9.
13. Roka S, Rasoul-Rockenschaub S, Roka J, Kirnbauer R, Muhlbacher F, Salat A. Prevalence of anal HPV infection in solid-organ transplant patients prior to immunosuppression. Transpl Int 2004; 17: 366-9.
14. Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000; 342: 792-800.
15. Coquard R. Merkel cell carcinoma of the anal canal: importance of radiotherapy. Dis Colon Rectum 2004; 47: 256-7. Author reply 7.
16. Garneski KM, DeCaprio JA, Nghiem P. Does a new polyomavirus contribute to Merkel cell carcinoma? Genome Biol 2008; 9: 228.
17. Khan MY, Khanam H, Koneru B, Schwartz RA. Kaposi's sarcoma in a liver transplant series. J Med 1999; 30: 185-90.
18. O'Connor JA, Cogley C, Burton M, Lancaster-Weiss K, Cordle RA. Posttransplantation lymphoproliferative disorder: endoscopic findings. J Pediatr Gastroenterol Nutr 2000; 31: 458-61.
19. Shapiro R, Young JB, Milford EL, Trotter JF, Bustami RT, Leichtman AB. Immunosuppression: evolution in practice and trends, 1993-2003. Am J Transplant 2005; 5(4 Pt 2): 874-86.
20. Boeckle E, Boesmueller C, Wiesmayr S, Mark W, Rieger M, Tabarelli D et al. Kaposi sarcoma in solid organ transplant recipients: a single center report. Transplant Proc 2005; 37: 1905-9.
21. Bonatti H, Hoefer D, Rogatsch H, Margreiter R, Larcher C, Antretter H. Successful management of recurrent Epstein-Barr virus-associated multilocular leiomyosarcoma after cardiac transplantation. Transplant Proc 2005; 37: 1839-44.
22. Dharancy S, Catteau B, Mortier L, Boleslawski E, Declerck N, Canva V et al. Conversion to sirolimus: a useful strategy for recalcitrant cutaneous viral warts in liver transplant recipient. Liver Transpl 2006; 12: 1883-7.
23. Zimmerman MA, Trotter JF, Wachs M, Bak T, Campsen J, Skibba A et al. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Liver Transpl 2008; 14: 633-8.
24. Tzakis A, Todo S, Starzl TE. Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg 1989; 210: 649-52.
25. Hellinger WC, Bonatti H, Machicao VI, Yao JD, Brumble LM, Alvarez S et al. Effect of antiviral chemoprophylaxis on adverse clinical outcomes associated with cytomegalovirus after liver transplantation. Mayo Clin Proc 2006; 81: 1029-33.
26. Clark JC, Collan Y, Eide TJ, Esteve J, Ewen S, Gibbs NM et al. Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. Int J Cancer 1985; 36: 179-86.
27. Murakami R, Tsukuma H, Kanamori S, Imanishi K, Otani T, Nakanishi K et al. Natural history of colorectal polyps and the effect of polypectomy on occurrence of subsequent cancer. Int J Cancer 1990; 46: 159-64.
28. Jorgensen OD, Kronborg O, Fenger C. A randomized surveillance study of patients with pedunculated and small sessile tubular and tubulovillous adenomas. The Funen Adenoma Follow-up Study. Scand J Gastroenterol 1995; 30: 686-92.
29. Bresci G, Parisi G, Capria A. Clinical relevance of colonic lesions in cirrhotic patients with portal hypertension. Endoscopy 2006; 38: 830-5.
30. Gravante G, Delogu D, Venditti D. Upper and lower gastrointestinal diseases in liver transplant candidates. Int J Colorectal Dis 2008; 23: 201-6.
31. Ishikawa S, Kato J, Kuriyama M, Takemoto K, Uraoka T, Takaki A, Yagi T, Sakaguchi K. Feasibility and findings of colonoscopy for living-donor liver transplant candidates. J Clin Gastroenterol 2009; 43: 69-74.
32. Rabinovitz M, Schade RR, Dindzans VJ, Belle SH, Van Thiel DH, Gavaler JS. Colonic disease in cirrhosis. An endoscopic evaluation in 412 patients. Gastroenterology 1990; 99: 195-9.
33. Bochud M, Burnand B, Froehlich F, Dubois RW, Vader JP, Gonvers JJ XIII. Appropriateness of colonoscopy: surveillance after curative resection of colorectal cancer. Endoscopy 1999; 31: 664-72.
34. Bochud M, Burnand B, Froehlich F, Dubois RW, Vader JP, Gonvers JJ XII. Appropriateness of colonoscopy: surveillance after polypectomy. Endoscopy 1999; 31: 654-63.
35. Croizet O, Moreau J, Arany Y, Delvaux M, Rumeau JL, Escourrou J. Follow-up of patients with hyperplastic polyps of the large bowel. Gastrointest Endosc 1997; 46: 119-23.
36. Jain AB, Yee LD, Nalesnik MA, Youk A, Marsh G, Reyes J et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998; 66: 1193-200.
37. Fabia R, Levy MF, Testa G, Obiekwe S, Goldstein RM, Husberg BS et al. Colon carcinoma in patients undergoing liver transplantation. Am J Surg 1998; 176: 265-9.
38. Haagsma EB, Hagens VE, Schaapveld M, van den Berg AP, de Vries EG, Klompmaker IJ et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 2001; 34: 84-91.
39. Papaconstantinou HT, Sklow B, Hanaway MJ, Gross TG, Beebe TM, Trofe J et al. Characteristics and survival patterns of solid organ transplant patients developing de novo colon and rectal cancer. Dis Colon Rectum 2004; 47: 1898-903.
40. Newcomb PA, Storer BE, Marcus PM. Cancer of the large bowel in women in relation to alcohol consumption: a case-control study in Wisconsin (United States). Cancer Causes Control 1993; 4: 405-11.
41. Su LJ, Arab L. Alcohol consumption and risk of colon cancer: evidence from the national health and nutrition examination survey I epidemiologic follow-up study. Nutr Cancer 2004; 50: 111-9.
42. Bardou M, Montembault S, Giraud V, Balian A, Borotto E, Houdayer C et al. Excessive alcohol consumption favours high risk polyp or colorectal cancer occurrence among patients with adenomas: a case control study. Gut 2002; 50: 38-42.
43. Goldbohm RA, Van den Brandt PA, Van't Veer P, Dorant E, Sturmans F, Hermus RJ. Prospective study on alcohol consumption and the risk of cancer of the colon and rectum in the Netherlands. Cancer Causes Control 1994; 5: 95-104.
44. Saigal S, Norris S, Muiesan P, Rela M, Heaton N, O'Grady J. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl 2002; 8: 482-7.
45. Vallejo GH, Romero CJ, de Vicente JC. Incidence and risk factors for cancer after liver transplantation. Crit Rev Oncol Hematol 2005; 56: 87-99.
46. Patel HS, Silver AR, Northover JM. Anal cancer in renal transplant patients. Int J Colorectal Dis 2007; 22: 1-5.
47. Hayanga A. Need for guidelines for screening in anal cancer: a lesson from cervical cancer. Dis Colon Rectum 2006; 49: 1079-80.
48. Scholefield JH, Castle MT, Watson NF. Malignant transformation of high-grade anal intraepithelial neoplasia. Br J Surg 2005; 92: 1133-6.
49. Bonatti H, Aigner F, De Clercq E, Boesmueller C, Widschwendner A, Larcher C et al. Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients. Transpl Int 2007; 20: 238-46.
50. Libertiny G, Watson CJ, Gray DW, Welsh KI, Morris PJ. Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients. Br J Surg 2001; 88: 1330-4.
51. Shapiro R, Nalesnik M, McCauley J, Fedorek S, Jordan ML, Scantlebury VP et al. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 1999; 68: 1851-4.
52. Nalesnik MA. Involvement of the gastrointestinal tract by Epstein-Barr virus-associated posttransplant lymphoproliferative disorders. Am J Surg Pathol 1990; 14(Suppl. 1): 92-100.
53. Younes BS, Ament ME, McDiarmid SV, Martin MG, Vargas JH. The involvement of the gastrointestinal tract in posttransplant lymphoproliferative disease in pediatric liver transplantation. J Pediatr Gastroenterol Nutr 1999; 28: 380-5.
54. Ghobrial IM, Habermann TM, Maurer MJ, Geyer SM, Ristow KM, Larson TS et al. Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders. J Clin Oncol 2005; 23: 7574-82.
55. Allen UD, Farkas G, Hebert D, Weitzman S, Stephens D, Petric M et al. Risk factors for post-transplant lymphoproliferative disorder in pediatric patients: a case-control study. Pediatr Transplant 2005; 9: 450-5.